Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Depreciation and Depletion (2016 - 2019)

Amicus Therapeutics filings provide 6 years of Depreciation and Depletion readings, the most recent being $991000.0 for Q1 2019.

  • On a quarterly basis, Depreciation and Depletion rose 2.27% to $991000.0 in Q1 2019 year-over-year; TTM through Mar 2019 was $4.2 million, a 12.92% increase, with the full-year FY2025 number at $3.9 million, down 22.0% from a year prior.
  • Depreciation and Depletion hit $991000.0 in Q1 2019 for Amicus Therapeutics, down from $1.2 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.2 million in Q4 2018 to a low of $353000.0 in Q2 2015.
  • Median Depreciation and Depletion over the past 5 years was $873500.0 (2016), compared with a mean of $830125.0.
  • Biggest five-year swings in Depreciation and Depletion: fell 10.86% in 2015 and later soared 126.84% in 2016.
  • Amicus Therapeutics' Depreciation and Depletion stood at $395000.0 in 2015, then skyrocketed by 129.37% to $906000.0 in 2016, then rose by 22.19% to $1.1 million in 2017, then grew by 7.05% to $1.2 million in 2018, then dropped by 16.37% to $991000.0 in 2019.
  • The last three reported values for Depreciation and Depletion were $991000.0 (Q1 2019), $1.2 million (Q4 2018), and $1.1 million (Q3 2018) per Business Quant data.